Who makes SAD, SHR-2004?

SAD, SHR-2004 is developed by Beijing Suncadia Pharmaceuticals Co., Ltd.

Last reviewed 2026-04-19 · How we verify

SAD, SHR-2004

Beijing Suncadia Pharmaceuticals Co., Ltd · Phase 1 active Small molecule

At a glance

Generic name	SAD, SHR-2004
Sponsor	Beijing Suncadia Pharmaceuticals Co., Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SAD, SHR-2004 CI brief — competitive landscape report
SAD, SHR-2004 updates RSS · CI watch RSS
Beijing Suncadia Pharmaceuticals Co., Ltd portfolio CI